register

News & Trends - Biotechnology

Merck and Microsoft partnerships support Australian-developed COVID-19 vaccine

Health Industry Hub | August 31, 2020 |

Biotech News: COVAX-19 is the first Australian-developed COVID-19 vaccine to pass phase I clinical trials in Australia successfully. Phase II clinical trials are set to begin in September 2020.

Professor Nikolai Petrovsky is the Director of Endocrinology at Flinders Medical Centre, a Professor in the School of Medicine at Flinders University and the founder of Vaxine Pty Ltd, an Adelaide-based biotechnology company specialising in pandemic vaccine design.

COVAX-19 vaccine comprises a recombinant spike protein antigen formulated with Vaxine’s proprietary Advax adjuvant, which drives a potent T cell and neutralising antibody response against the target virus.

The Microsoft AI and Azure cloud capabilities will help the company accelerate clinical testing of its COVAX-19 vaccine.

“Large international Phase III vaccine trials are extraordinarily complex and generate vast amounts of data that needs to be efficiently processed”, says Vaxine Research Director, Flinders University Professor Nikolai Petrovsky.

“Supported by Microsoft technology, we aim to collect and analyse the COVAX-19 trial data in real time, rather than waiting until the end of the trial before seeing if the vaccine is working, which is the traditional process.”

Merck Life Sciences, Managing Director, Rebecca Lee, conducted a recent Q&A video interview with Professor Nikolai Petrovsky.

Join 22,000+
industry professionals
in accessing the latest 
industry news, scientific insights & engaging professional development 
content from
Health Industry HubTM, 
the ONLY one-stop-hub
connecting Australia’s 
Pharma, MedTech & Biotech
industry professionals. Register now.

Merck has a long-standing relationship with Sypharma and Vaxine for more than 10 years, supporting the manufacture of Advax adjuvants with manufacturing solutions, single-use, filtration products and process development expertise.


News & Trends - MedTech & Diagnostics

Medtronic, J&J MedTech and Edwards Lifesciences senior leaders reflect on 2023 and voice outlook for the year ahead

Medtronic, J&J MedTech and Edwards Lifesciences senior leaders reflect on 2023 and voice outlook for the year ahead

Health Industry Hub | December 7, 2023 |

MedTech & Diagnostics News: As we approach the end of 2023, senior leaders in the medtech sector, including Medtronic, Johnson […]

More


News & Trends - Pharmaceuticals

Sanofi, AstraZeneca and BeiGene senior leaders reflect on 2023 and voice outlook for the year ahead

Sanofi, AstraZeneca and BeiGene senior leaders reflect on 2023 and voice outlook for the year ahead

Health Industry Hub | December 7, 2023 |

Pharma News: As 2023 draws to a close, senior leaders in the pharmaceutical and biotechnology sectors paused to reflect on […]

More


Medical

AbbVie leader takes helm as President of medical affairs association

AbbVie leader takes helm as President of medical affairs association, emphasising optimism fuelled by collaboration

Health Industry Hub | December 7, 2023 |

Medical: The Medical Affairs Professionals of Australasia (MAPA) has revealed its newly appointed President and executive committee for 2024. Lauren […]

More


News & Trends - MedTech & Diagnostics

National Cabinet endorses hospital funding overhaul as surgery waiting lists skyrocket beyond 850,000

National Cabinet endorses hospital funding overhaul as surgery waiting lists skyrocket beyond 850,000

Health Industry Hub | December 7, 2023 |

MedTech & Diagnostics News: National Cabinet met in Canberra yesterday to make progress on key health reforms. National Cabinet endorsed […]

More


This content is copyright protected. Please subscribe to gain access.